Gunderson Dettmer and Skadden advised Anaplan on the deal. Kirkland and Ellis and Cadwalader, Wickersham & Taft advised Thoma Bravo. Latham & Watkins represented the direct...
Thoma Bravo’s Acquisition of Anaplan
Theseus Pharmaceuticals’ $160 Million IPO
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Theseus Pharmaceuticals on the deal. Theseus Pharmaceuticals, Inc., a biopharmaceutical company focused on improving the lives of cancer...
Synchronoss’ Two Public Offerings and Private Placement
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Synchronoss on the deal. Synchronoss Technologies, Inc. (NASDAQ: SNCR), a global leader and innovator of cloud, messaging and...
TuSimple’s $1.35 Billion Initial Public Offering
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised TuSimple on the deal, while Davis Polk advised the representatives of the several underwriters. TuSimple, a San...